The BIEL/Electrome narrative is a natural fit for MrBeast following his 2026 acquisition of Step.
Why BIEL/Electrome Fits "Beast Financial"
The acquisition of Step wasn't just about banking; it was about "Beast Industries" entering the financial infrastructure space. The BIEL story—centered on BioElectronics Corp and its wearable pain-relief tech—offers exactly the kind of high-stakes, disruptive content Jimmy Donaldson uses to grow his brands.
Financial Literacy & Impact Investing: With Step, MrBeast wants to teach young people about investing. The BIEL story is a textbook example of a "micro-cap" or "penny stock" ($BIEL is currently trading around $0.0003 as of March 2026). He could use it to show the reality of high-risk investing versus long-term value.
The Medical "Miracle" Hook: MrBeast has a track record of "curing" ailments (blindness, hearing loss). BIEL’s ActiPatch technology claims to use electromagnetic fields to treat chronic pain without drugs. This provides a perfect "Beast Philanthropy" angle: "I gave 50,000 people their lives back without using opioids."
Challenging the Status Quo: Just as Step challenges traditional banks, the Electrome/BIEL story is often framed by its retail investor community as a battle against "Big Pharma" and institutional short-sellers. This "underdog vs. the system" narrative is the bread and butter of MrBeast’s storytelling.
Gamified Rewards: Through the Step app, he could potentially offer rewards or "stock drops" for users who engage with medical research or philanthropic causes, turning a complex bioelectronics story into a viral financial event.
Comparison of the Two Ventures
Step (The Platform):
Focus: Youth banking, credit building, and now crypto/stock trading.
Scale: Over 7 million teen users as of March 2026.
Value: Providing the financial "foundation" for the next generation.
BIEL / Electrome (The Content/Mission):
Focus: Electroceutical medical devices for chronic pain.
Scale: Small-cap medical tech with a highly vocal "retail" investor base.
Value: Potential for massive philanthropic impact and "David vs. Goliath" financial drama.
Why BIEL/Electrome Fits "Beast Financial"
The acquisition of Step wasn't just about banking; it was about "Beast Industries" entering the financial infrastructure space. The BIEL story—centered on BioElectronics Corp and its wearable pain-relief tech—offers exactly the kind of high-stakes, disruptive content Jimmy Donaldson uses to grow his brands.
Financial Literacy & Impact Investing: With Step, MrBeast wants to teach young people about investing. The BIEL story is a textbook example of a "micro-cap" or "penny stock" ($BIEL is currently trading around $0.0003 as of March 2026). He could use it to show the reality of high-risk investing versus long-term value.
The Medical "Miracle" Hook: MrBeast has a track record of "curing" ailments (blindness, hearing loss). BIEL’s ActiPatch technology claims to use electromagnetic fields to treat chronic pain without drugs. This provides a perfect "Beast Philanthropy" angle: "I gave 50,000 people their lives back without using opioids."
Challenging the Status Quo: Just as Step challenges traditional banks, the Electrome/BIEL story is often framed by its retail investor community as a battle against "Big Pharma" and institutional short-sellers. This "underdog vs. the system" narrative is the bread and butter of MrBeast’s storytelling.
Gamified Rewards: Through the Step app, he could potentially offer rewards or "stock drops" for users who engage with medical research or philanthropic causes, turning a complex bioelectronics story into a viral financial event.
Comparison of the Two Ventures
Step (The Platform):
Focus: Youth banking, credit building, and now crypto/stock trading.
Scale: Over 7 million teen users as of March 2026.
Value: Providing the financial "foundation" for the next generation.
BIEL / Electrome (The Content/Mission):
Focus: Electroceutical medical devices for chronic pain.
Scale: Small-cap medical tech with a highly vocal "retail" investor base.
Value: Potential for massive philanthropic impact and "David vs. Goliath" financial drama.
1
